Partnerships
Stronger Partnerships. Healthier Futures.
At LunaVax, partnerships drive both our innovation and impact — from developing next-generation vaccines to powering our delivery model, the LunaChain. Whether it’s advancing R&D, scaling local manufacturing, or reaching last-mile communities, we collaborate with mission-aligned allies to build stronger, more equitable systems for vaccine access

How We Work With Partners
1. LunaVax Collaboratives
We team up with global health leaders, research institutions, and mission-aligned partners to co-develop vaccine innovations, support local manufacturing, and expand access to life-saving immunizations. These collaborations help advance next-generation platforms like mRNA, saRNA, protein subunit, viral vector, DNA-based vaccines, and microneedle patches—tailored to Africa’s health priorities.
2. Tech Partnerships
3. Research & Development
Through our R&D partnerships, we co-create new vaccine solutions for the continent’s evolving needs. These partnerships focus on next-gen science and novel delivery methods, ensuring our platforms stay adaptive, scalable, and data-driven from lab to last mile.
4. Community Engagement & Awareness
We engage with clinics, pharmacies, governments, NGOs, and public health agencies to boost vaccine awareness, reduce hesitancy, and build trust in new delivery models. These partnerships foster education, community participation, and pilot testing—laying the groundwork for future vaccine distribution. Together, we work to ensure underserved communities receive timely, equitable immunization.
As part of this effort — our current MAP pilot in Lagos and Abuja engages local clinics, pharmacies, and public health partners to build trust in new delivery models and test LunaChain’s potential in the field.